Prosera
The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or III. The secondary objective for this trial is to determine time to clinical worsening.
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Hemotag
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder
The main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.
- Investigator
- Ali Ataya
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
